BioCentury
ARTICLE | Clinical News

ART-123: Phase IIb started

August 27, 2007 7:00 AM UTC

Artisan began a double-blind, placebo-controlled, international Phase IIb trial (2-001) in 800 patients. Artisan spun out of Asahi last year with rights to ART-123 outside of Japan, China, Taiwan and ...